Michael DiVecchia

Chief Operating Officer at Elicio Therapeutics, Inc. (Old)

Health Technology

Consumer Services

Profile

Michael DiVecchia is currently working as the Vice President of Operations & Program Management at Elicio Therapeutics, Inc. (United States).
Previously, he held the position of Senior VP of Operations & Human Resources at Elicio Therapeutics, Inc. from 2022 to 2024.
He completed his undergraduate degree at Syracuse University.

Michael DiVecchia active positions

Companies	Position	Start
Elicio Therapeutics, Inc. (Old) Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA.	Chief Operating Officer	-

All active positions of Michael DiVecchia

Former positions of Michael DiVecchia

Companies	Position	End
ELICIO THERAPEUTICS, INC.	Chief Operating Officer	31/12/2023

See the detail of Michael DiVecchia's experience

Training of Michael DiVecchia

Syracuse University

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Michael DiVecchia's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
ELICIO THERAPEUTICS, INC.	Health Technology

Private companies	1
Elicio Therapeutics, Inc. (Old) Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA.	Health Technology